SEC 13F Intelligence

Managers / Q4 2019 · view latest →

Bellevue Group AG

CIK 0001674546 · THEATERSTRASSE 12, ZURICH, CH-8001 · 41 44 267 67 77

Reported Value
$6.3B
Q4 2019
Positions
239
Filings on Record
30
2019–present window
Filed
Feb 14, 2020
original filing

Summary

Bellevue Group Ag reported $6.3B in U.S.-listed holdings across 239 positions for Q4 2019.

Its largest position, ISI, represents 7.7% of the portfolio.

Compared with Q3 2019, the fund opened 22 new positions and exited 17.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $1.5BQ4 ’18Q1 ’19: $1.8BQ2 ’19: $5.9BQ3 ’19: $5.4BQ4 ’19: $6.3BQ4 ’19Q1 ’20: $5.2BQ2 ’20: $7.1BQ3 ’20: $7.2BQ4 ’20: $8.7BQ4 ’20Q1 ’21: $9.5BQ2 ’21: $10.2BQ3 ’21: $9.9BQ4 ’21: $9.7BQ4 ’21Q1 ’22: $8.6BQ2 ’22: $7.1BQ3 ’22: $7.0BQ4 ’22: $7.53TQ4 ’22Q1 ’23: $6.9BQ2 ’23: $7.0BQ3 ’23: $6.2BQ4 ’23: $6.5BQ4 ’23Q1 ’24: $6.6BQ2 ’24: $6.2BQ3 ’24: $6.2BQ4 ’24: $5.2BQ4 ’24Q1 ’25: $4.5BQ2 ’25: $4.5BQ3 ’25: $4.8BQ4 ’25: $5.3BQ4 ’25Q1 ’26: $4.2Bfilingsflow.com

Portfolio Composition

By security type

Composition data arrives with ticker enrichment.

Quarter-over-Quarter Changes full breakdown →

Holdings — Q4 2019

Loading…
Export to Excel
#IssuerClass% PortfolioValue ↓Shares

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$4.2B167May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$5.3B213Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$4.8B186Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$4.5B175Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$4.5B177May 14, 202513F-HRchanges · EDGAR ↗
Q4 2024$5.2B193Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$6.2B196Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$6.2B204Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$6.6B208May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$6.5B202Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$6.2B196Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$7.0B198Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$6.9B202May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$7.53T215Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$7.0B217Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$7.1B214Aug 11, 202213F-HRchanges · EDGAR ↗
Q1 2022$8.6B220May 13, 202213F-HRchanges · EDGAR ↗
Q4 2021$9.7B235Feb 10, 202213F-HRchanges · EDGAR ↗
Q3 2021$9.9B265Nov 12, 202113F-HRchanges · EDGAR ↗
Q2 2021$10.2B262Aug 12, 202113F-HRchanges · EDGAR ↗
Q1 2021$9.5B260May 12, 202113F-HRchanges · EDGAR ↗
Q4 2020$8.7B266Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$7.2B261Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$7.1B235Aug 13, 202013F-HRchanges · EDGAR ↗
Q1 2020$5.2B239May 14, 202013F-HRchanges · EDGAR ↗
Q4 2019$6.3B239Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$5.4B236Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$5.9B219Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$1.8B138May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$1.5B138Feb 12, 201913F-HRchanges · EDGAR ↗

Other Included Managers

This filing reports holdings on behalf of 2 additional managers.

  • BB Biotech AG28-06964
  • Bellevue Asset Management AG28-16892

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.